Results 131 to 140 of about 19,620 (155)

[A case of drug-induced hypersensitivity syndrome combined with acute hepatitis E]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Ji TT, Wang TL, Xing HC, Ren YY, Yu YY, Yao TT, Wang S, Xu JH.   +7 more
europepmc   +1 more source

[Reflections on the novel definition and whether or not antiviral therapy for inactive HBsAg carrier state in the "Guidelines for the Prevention and Treatment of Chronic Hepatitis B (version 2022)"]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Ren S, Zheng SJ, Chen XY.
europepmc   +1 more source

[Predictive role of dynamic changes in liver stiffness measurement for liver-related endpoint events in chronic hepatitis B]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Sun CL, Chen SY, Wu XN, Zhou JL, Meng TT, Wang BQ, Zhao XY, Ou XJ, Jia JD, Sun YM, You H.   +10 more
europepmc   +1 more source

[Controversy and consensus on antiviral treatment strategies for low-level hepatitis B surface antigens]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Hou YH, Zhang LY.
europepmc   +1 more source

B 型肝炎ウイルス関連抗原およびδ抗原の肝細胞内局在と病態について : 免疫電顕による検討 [PDF]

, 1987
小島 隆
core   +1 more source

[Introduction of the key update points of the 2025 Canadian Association for the Study of the Liver guideline for the management of chronic hepatitis B]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Zhuang H.
europepmc   +1 more source

[Research progress on new drugs for the treatment of chronic hepatitis B virus infection]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Yu YY, Li J, Wang WX, Fan PY, Wang FS.
europepmc   +1 more source

[A case of hepatitis B surface antigen clearance achievement based on the combination of interferon and intermittent consolidation therapy]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Deng W, Wang SY, Wei X, Cao WH, Xie Y, Li MH.   +5 more
europepmc   +1 more source

[Wilson's disease misdiagnosed as autoimmune hepatitis: a case report and literature review]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Chen LF, Wan YP, Xiao LM, Li D, Wen ZL, Yang LL.   +5 more
europepmc   +1 more source

[How far has non-invasive testing become a surrogate endpoint for the research and development of new drugs for metabolic dysfunction-associated steatohepatitis?] [PDF]

Zhonghua Gan Zang Bing Za Zhi
Sun YM, You H.
europepmc   +1 more source